Engflag

Amorion

Quick links to important sections

Amorion

Selected form

Amorion_EN

Method of action: Bactericidal

Treatment option: Abscess, Lung Abscess, Pregnancy, Asymptomatic bacteriuria, Lyme Disease, Bronchitis, Community Acquired Pneumonia, Gonorrhea, Infection, Middle Ear Infection

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amorion

This section defines the identity, classification, and general purpose of the medication Amorion, which contains the active ingredient Amoxicillin.

Amorion Quick Facts

Property Description
Active ingredient Amoxicillin trihydrate
Common Forms Capsules, Tablets, Powder for Oral Suspension
Pharmacological Class Penicillin Antibiotic (Aminopenicillin)
General Purpose Treatment of susceptible bacterial infections
Origin Semisynthetic beta-Lactam Derivative

What Type of Medicine is Amorion?

Amorion is a prescription drug classified as an antibiotic, utilizing Amoxicillin as its core active ingredient. It belongs to the Penicillin family, specifically the Aminopenicillin subclass, derived from a natural penicillin nucleus but chemically modified to be a semisynthetic beta-lactam derivative. This classification is characterized by its bactericidal efficacy against a broad range of bacterial pathogens. This structural characteristic makes Amoxicillin a clinically recognized agent for initial treatment protocols against common bacterial infections in the ear, nose, throat, and lower respiratory tract.

Composition and Available Forms

The therapeutic effect of Amorion is delivered by Amoxicillin trihydrate. Amorion is produced in several common dosage forms primarily for the oral route of administration, including capsules, solid tablets, and a powder for oral suspension which is reconstituted to create an oral liquid. This liquid form is often focused on the pediatric patient group due to ease of swallowing. While the drug is typically used as a single agent, it is often necessary to combine Amoxicillin with an inhibitor, such as Clavulanic acid, to protect the compound from enzymatic destruction. This combination strategy is essential for making the medicine effective against enzyme-producing strains of bacteria.

What is Amorion's General Purpose?

The general purpose of Amorion is to resolve active bacterial infections by directly eliminating the causative bacteria. This is achieved through its bactericidal mechanism, which works by weakening the structural integrity of the bacterial cell wall, leading to the organism's rupture and death. This direct-kill approach is crucial for achieving rapid control and resolution of bacterial disease processes, such as overcoming an acute respiratory infection caused by susceptible bacteria.

Regulatory References

  1. WHO Model List of Essential Medicines
  2. Amoxicillin - StatPearls - NCBI Bookshelf

What side effects are possible with Amorion?

Possible Side Effects and Safety Information

The official safety information for Amorion (Amoxicillin) details potential adverse reactions classified by frequency and affected body system, strictly based on government regulatory documentation.

Adverse reactions are primarily classified into Common, Uncommon, and Very Rare categories. Common effects typically involve the gastrointestinal system (e.g., diarrhea, nausea, vomiting) and skin (e.g., rash). Uncommon reactions include pruritus (itching) and urticaria. Mucocutaneous candidiasis is also a common, documented effect.

Classification Examples of Adverse Reactions (SOC)
Common Diarrhea, Nausea, Vomiting, Rash
Uncommon Pruritus, Urticaria
Very Rare Anaphylactic reaction, Convulsions, Hepatitis

Serious adverse reactions, though very rare, are explicitly documented in regulatory labeling. These include severe hypersensitivity reactions like anaphylaxis and severe cutaneous adverse reactions (SCAR) such as Stevens-Johnson Syndrome (SJS) and DRESS. Furthermore, Clostridioides difficile-associated diarrhea (CDAD) and cholestatic jaundice are noted as serious potential effects. Convulsions have been reported, particularly in patients with pre-existing renal impairment.

Specific safety constraints are defined in the labeling. Amorion is contraindicated in individuals with a known history of a serious hypersensitivity reaction to any penicillin-class or other beta-lactam antibacterial agents. A high risk of skin rash is associated with its use in patients with infectious mononucleosis. Treatment must be discontinued if a severe allergic reaction or SCAR develops, and dosage adjustment is required for patients with severe renal impairment. Non-urticarial skin rash is often observed early in the course of therapy.

Overdose and Emergency Response

Overdose and when to seek help

The following information is based strictly on descriptions of overdose and emergency procedures found in government regulatory documents for Amoxicillin (Amorion).

Documented Manifestations and Severe Outcomes

Classification Official Regulatory Statements
Documented Manifestations Overdose primarily presents with gastrointestinal disturbances, including nausea, vomiting, and diarrhea. Signs of crystalluria (crystals in the urine) are noted [NIH StatPearls].
Serious Outcomes Potential for acute renal failure resulting from severe crystalluria and convulsions or seizures is documented, particularly in patients with pre-existing impaired kidney function [NAFDAC SmPC].
Population-Specific Note Patients with impaired renal function are at a heightened risk for severe central nervous system effects [NAFDAC SmPC].

Required Emergency Actions and Management

Seeking Immediate Medical Attention

Regulatory authorities mandate that immediate medical attention be sought for any suspected overdose. Emergency services must be contacted immediately if the affected person shows severe signs, such as a seizure, is difficult to awaken, or has collapsed [MedlinePlus].

Management and Supportive Care

The management documented in official labeling is symptomatic and supportive treatment. No specific antidote is known for Amoxicillin overdose. Treatment measures include maintaining adequate fluid intake to assist the kidneys in preventing crystalluria. Hemodialysis is documented as a procedure that can remove the drug from circulation.

Therapeutic Uses of Amorion

What Amorion Treats: Main Uses and Benefits

Amorion is a medication that is commonly used to help manage symptoms related to active bacterial infections. It is applied across therapeutic domains where additional symptomatic support is needed and is relevant for easing discomfort related to the infection. Its use is established across several major therapeutic areas.

Amorion is commonly used to address conditions marked by acute or episodic symptom patterns, primarily involving the ear, nose, and throat (ENT) infections, as well as lower respiratory tract infections, skin infections, and certain urinary tract infections (UTIs). The medication offers symptomatic relief that helps ease the overall burden of disruptive manifestations like sore throat, ear pain, fever, and persistent cough.

It is also applied in specific scenarios, such as the management of dental abscesses and in prophylactic clinical scenarios to manage the risk of infection in certain high-risk patients. The primary therapeutic support contributes to improved day-to-day comfort during periods of heightened symptoms. This supportive role helps patients cope more steadily with difficult episodes and may assist with maintaining functional stability when symptoms become more noticeable.

Amorion Quick Fact
Support for Acute Symptoms Assists with managing symptoms related to conditions like otitis media and tonsillitis.

Eligibility and Restrictions for Use

The eligibility for using Amorion (Amoxicillin) is strictly defined by government regulatory documents, focusing on patient history, age, and organ function.

Contraindications and Restrictions

Classification Population/Condition
Contraindicated Patients with a known serious hypersensitivity to Amoxicillin or any other beta-Lactam antibiotic (e.g., penicillin class).
Use Not Recommended Patients with Infectious Mononucleosis (Glandular Fever) due to a high risk of developing a non-allergic skin rash.
Restricted Use Patients with severe renal impairment (GFR < 30 mL/min), as the risk of toxic reactions is greater and formal dose adjustment is required.

Population Eligibility

Age-Related Rules: Amorion is approved for use in adults and pediatric patients generally over three months of age. Infants and neonates (leq 3 months) have a formal maximum daily dosage restriction (30 mg/kg/day divided every 12 hours) due to incompletely developed renal function. Older adults may require dose adjustment if they have decreased kidney function.

Pregnancy and Lactation: Use during pregnancy is generally considered acceptable as limited human data do not indicate an increased risk of congenital malformations. During lactation, use is generally permitted, though the drug is excreted in low quantities in breast milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products — Official Regulatory Information for Amorion

Category
Medicinal Products with Documented Interactions Oral Anticoagulants (e.g., Warfarin), Combined Oral Contraceptives, Allopurinol, Probenecid, and Bacteriostatic Antibacterials.
Mechanistic Basis of Interactions Inhibition of renal tubular secretion (with Probenecid) and alteration of gut flora leading to reduced estrogen reabsorption (with oral contraceptives).
Timing-Based Rules/Restrictions None explicitly documented as mandatory co-administration prohibitions or time-separation rules.
Population-Specific Interaction Notes The increased risk of bleeding with oral anticoagulants is observed to be heightened in the elderly and individuals with renal or hepatic impairment.

Official Interaction Statements:

  • Probenecid: Co-administration results in a pharmacokinetic interaction that inhibits the drug’s renal tubular secretion, leading to officially documented increased blood levels (plasma concentrations) of Amorion.
  • Oral Anticoagulants: Concomitant use may lead to a pharmacodynamic effect, resulting in the officially documented prolongation of prothrombin time (INR).
  • Combined Oral Contraceptives: Amorion may reduce the efficacy of combined oral contraceptives due to altered gut flora affecting estrogen reabsorption.
  • Allopurinol: Co-administration is formally associated with an increased incidence of rash.

The regulatory documentation formally defines Amorion’s interaction structure primarily through two domains: alteration of its own clearance pathway and pharmacodynamic effects on other medicines, such as coagulation and contraceptive efficacy. Official labeling specifies resulting constraints, including the requirement for prothrombin time monitoring when used concurrently with anticoagulants. This summary strictly reflects the consequences of co-administration as verified by the authorizing regulatory bodies.

Mechanism of Action

Amorion is a combination pharmacologic agent consisting of amoxicillin and clavulanic acid. Amoxicillin, a beta-lactam derivative, acts as an irreversible inhibitor of bacterial transpeptidases, a class of enzymes termed penicillin-binding proteins (PBPs), which are localized in the inner aspect of the bacterial cell wall.

Amoxicillin's binding to these PBPs prevents the transpeptidation reaction, which is a critical terminal step in the biosynthesis and cross-linking of the peptidoglycan layer. The inhibition of this process compromises the structural integrity of the cell wall, leading to a loss of osmotic stability and subsequent bacterial cell lysis.

Clavulanic acid, possessing negligible intrinsic antimicrobial activity, functions as a suicide inhibitor of beta-lactamase enzymes. These enzymes, produced by certain bacteria, hydrolyze the beta-lactam ring of amoxicillin, rendering it inactive. By irreversibly binding to the beta-lactamase active site, clavulanic acid safeguards the beta-lactam structure of amoxicillin, thereby extending amoxicillin's inhibitory action against the PBPs of beta-lactamase-producing bacterial populations.

Dosage and Administration Information

Instruction Map: How to use Amorion

This map details the instructions for using Amorion (Amoxicillin).

Administration Scope

Parameter Instruction Details
Route of administration Primarily Oral (PO) via tablets, capsules, or suspension. Sterile formulations also exist for Intravenous (IV) and Intramuscular (IM) administration in clinical settings.
Dosing schedule Standard divided doses are administered either every 8 hours or every 12 hours. Adult doses for routine infections range from 250 mg to 875 mg per administration. Specialized protocols include a single oral dose of 3 grams for specific conditions.
Timing in relation to meals (if applicable) May generally be taken with or without food. However, the modified-release 775 mg tablet is an exception and must be taken within 1 hour of finishing a meal.
Preparation requirements (if applicable) The Powder for Oral Suspension must be shaken well before each use and measured with a calibrated dosing device. Modified-release tablets must be swallowed whole and cannot be crushed or chewed.
Age-group administration rules Pediatric dosing is calculated based on body weight (mg/kg/day) for children under 40 kg. Adult patients with severe renal impairment must receive a reduced dose, and the 875 mg dose is prohibited in this population.
Course duration / cycle information Treatment typically lasts no more than 14 days. Infections caused by Streptococcus pyogenes require a minimum course of 10 days.

Instruction Classifications (High-level)

Classification Detail
Administration method type Oral / Parenteral (IV/IM)
Frequency pattern Fixed Interval (Every 8 hours / Every 12 hours) / Once Daily / Single Dose
Use-context constraints Renal function dependent; Weight-based dosing for pediatrics; Food-dependent (specific forms only); Preparation required (suspension/dispersible forms).

Connection to the overall use protocol

The use protocol establishes a structured framework for administration. This framework dictates the delivery method and numerical dose, sets temporal boundaries for dosing frequency and total course duration, and requires specific adjustments for administration technique and dose amount based on patient population characteristics.

Recent Clinical Evidence

Research evidence / Overview of studies for Amorion

Amorion (Amoxicillin) was studied for use in specific types of bacterial infections. The research evidence primarily consists of large randomized controlled trials (RCTs) and systematic reviews, which research examined to understand treatment outcomes for groups of patients. The research describes group patterns observed in the studies of Amoxicillin but does not determine whether an individual will respond similarly.

Evidence for Use in Acute Ear Infections (Acute Otitis Media)

Research on Amoxicillin was evaluated in numerous short-term RCTs, primarily including pediatric patients. Researchers monitored outcomes such as clinical success rates and bacteriological eradication. Some trials reported measurements of eradication at the end of the treatment period. Other findings describe patterns where measured symptom evolution in children was observed in comparison to groups receiving observation only, particularly in less severe cases. Research describes patterns indicating that the measured outcomes were influenced by the known susceptibility of the pathogen.

Evidence for Use in Throat Infections (Streptococcal Pharyngitis / Tonsillitis)

Amoxicillin was studied for its use in treating throat infections. The key outcomes research explored were the bacteriological eradication rate and the clinical success rate. The research describes patterns related to bacteriological eradication rates observed at the end of the standard study interval. Some comparative studies explored different protocols; the findings indicate patterns where measured eradication was observed to be similar to other study protocols.

What Remains Uncertain About the Research

The clinical evidence contains several research limitation frames. Follow-up durations were limited primarily to the short-term treatment phase, and long-term effects are not fully established. Comparative evidence is lacking for many antibiotic alternatives, which complicates contextualizing the findings. The measured outcomes are strongly associated with the susceptibility of the specific bacteria, meaning data for certain groups remain insufficient where resistance is known to be high. The findings describe group patterns, not personal outcomes.

Frequently Asked Questions (FAQ)

Common questions about Amorion (FAQ)

Q: Does this medicine interact with alcohol?

According to the official product information, Amorion may increase the sedative effects of alcohol. To minimize potential risks, regulatory documents caution against the consumption of alcoholic beverages while taking this product.

Q: Can I use this product on my 2-year-old child?

Official regulatory documents state that the safety and effectiveness of Amorion have not been established in pediatric patients under 4 years of age. Decisions regarding use for children outside of the labeled age group should be made in consultation with a healthcare professional.

Q: What should I do if I miss a dose of Amorion?

The official product information addresses missed doses. Specific instructions on how to manage a missed dose are provided in the Patient Information Leaflet or product labeling, typically advising against taking extra medicine to make up for a missed dose. Always follow the exact directions provided with the product.

Q: Does Amorion cause drowsiness or make me sleepy?

The official drug label includes warnings about the potential for Central Nervous System (CNS) effects, which can include dizziness, sedation, and drowsiness. Warnings regarding skilled tasks like driving or operating machinery are included on the label due to the potential for these effects.

How should Amorion be stored and disposed of?

Storage Conditions

The required storage conditions for Amorion depend on the dosage form. The solid forms, including capsules, tablets, and the dry powder for suspension, must be stored at controlled room temperature, typically below 25 C or 30 C, and protected from moisture to maintain stability.

Once the powder is mixed, the reconstituted liquid suspension must be stored under refrigeration (2 C-8 C) and has a short in-use shelf life, usually requiring disposal after 7 to 14 days.

All forms of the medicine must be stored out of the sight and reach of children.

Disposal Instructions

Unused or expired Amorion should be disposed of via drug take-back programs when available. Regulatory guidance advises that the medicine should not be flushed down the toilet or poured into the drain. If household trash disposal is necessary, the medicine should be mixed with an undesirable substance, placed in a sealed container, and then discarded. All personal information should be removed from the packaging beforehand.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagFinland

Equivalent of Amorion found in:

A-Z Index: